{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:21Z","timestamp":1786119141843,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1097\/coc.0b013e318162f13b","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T16:40:54Z","timestamp":1236271254000},"page":"340-344","source":"Crossref","is-referenced-by-count":20,"title":["Impact of Preexisting Pulmonary Fibrosis Detected on Chest Radiograph and CT on the Development of Gefitinib-Related Interstitial Lung Disease"],"prefix":"10.1097","volume":"31","author":[{"given":"Yoichi","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Minato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Shitara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Mogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Yamabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusei","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1378\/chest.128.1.452","article-title":"Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.","volume":"128","author":"Yang","year":"2005","journal-title":"Chest"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group.","volume":"311","year":"1995","journal-title":"BMJ"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","article-title":"Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].","volume":"21","author":"Fukuoka","year":"2003","journal-title":"J Clin Oncol"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","article-title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.","volume":"290","author":"Kris","year":"2003","journal-title":"JAMA"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/S0140-6736(05)67625-8","article-title":"Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).","volume":"366","author":"Thatcher","year":"2005","journal-title":"Lancet"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.1073\/pnas.0405220101","article-title":"EGF receptor gene mutations are common in lung cancers from \u201cnever smokers\u201d and are associated with sensitivity of tumors to gefitinib and erlotinib.","volume":"101","author":"Pao","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1158\/0008-5472.CAN-04-2818","article-title":"Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.","volume":"64","author":"Kosaka","year":"2004","journal-title":"Cancer Res"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1158\/1078-0432.CCR-04-1245","article-title":"High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.","volume":"10","author":"Huang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R12-6-20210128","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2005.01.388","article-title":"Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib.","volume":"23","author":"Han","year":"2005","journal-title":"J Clin Oncol"},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence.","volume":"23","author":"Mitsudomi","year":"2005","journal-title":"J Clin Oncol"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1200\/JCO.2005.05.4692","article-title":"Prospective phase II study of gefitinib for chemotherapy-naive patients with advanced non-small-cell lung cancer with epidermal growth factor receptor gene mutations.","volume":"24","author":"Inoue","year":"2006","journal-title":"J Clin Oncol"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(03)12190-3","article-title":"Severe acute interstitial pneumonia and gefitinib.","volume":"361","author":"Inoue","year":"2003","journal-title":"Lancet"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10147-004-0418-0","article-title":"Acute gefitinib-related pneumonitis.","volume":"9","author":"Ohyanagi","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00130404-200509000-00010","article-title":"Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.","volume":"11","author":"Hotta","year":"2005","journal-title":"Cancer J"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.lungcan.2004.01.010","article-title":"Risk factors for interstitial lung disease and predictive factors for tumor response in patients with advanced non-small cell lung cancer treated with gefitinib.","volume":"45","author":"Takano","year":"2004","journal-title":"Lung Cancer"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1200\/JCO.2005.04.9866","article-title":"Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib.","volume":"24","author":"Ando","year":"2006","journal-title":"J Clin Oncol"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1200\/JCO.2005.02.5825","article-title":"First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.","volume":"24","author":"Niho","year":"2006","journal-title":"J Clin Oncol"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1634\/theoncologist.8-4-303","article-title":"FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets.","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.1200\/jco.2005.23.16_suppl.7058","article-title":"Low incidence of pneumonitis on SWOG 0023: a preliminary analysis of an ongoing phase III trial of concurrent chemoradiotherapy followed by consolidation docetaxel and Iressa\/placebo maintenance in patients with inoperable stage III non-small cell lung cancer.","volume":"41","author":"Kelly","year":"2005","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-200808000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:51:27Z","timestamp":1786038687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200808000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e318162f13b","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}